Selective class IIa HDAC inhibition reverses diastolic dysfunction in cardiometabolic HFpEF
Huang, J.; Schreiter, F.; Fan, J.; Chen, Z.; Paluvai, H.; Withaar, C.; Oeing, C. U.; Saadatmand, A. R.; Schoger, E.; Haydar, S.; Elsherbiny, A.; Hagenmueller, M.; Lapouge, K.; Guimaraes-Camboa, N.; Falcao-Pires, I.; Hamdani, N.; Schulze, A.; Jansen, S.; Nolan, M. A.; Gilsbach, R.; de Boer, R. A.; Dewenter, M.; Backs, J.
Show abstract
Heart failure with preserved ejection fraction (HFpEF) is a highly prevalent cardiometabolic syndrome with yet no effective therapies. Here, we report that selectively class IIa histone deacetylases (HDACs) but no other classes of HDACs are enzymatically activated in hearts from HFpEF patients and cardiometabolic HFpEF animal models. Cell type-specific and enzymatic activity-specific genetic loss-of-function models of the cardiomyocyte-enriched class IIa HDAC family member HDAC4 and the pharmacological class IIa HDAC-selective inhibitor TMP195 prevent and reverse diastolic dysfunction and exercise intolerance in cardiometabolic HFpEF in vivo. In contrast to pan-HDAC inhibition no adverse effects are observed. Despite its well-known non-enzymatic role as transcriptional repressor, we found that specifically enzymatic activation of HDAC4 has little direct effects on cardiomyocyte-intrinsic gene expression. Instead, non-epigenetic actions lead to endothelial activation via altered cardiocrine signaling. We discovered that selective enzymatic class IIa HDAC inhibition is a new therapeutic concept to combat cardiac HFpEF.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Gain-of-function cardiomyopathic mutations in RBM20 rewire splicing regulation and re-distribute ribonucleoprotein granules within processing bodies 96%
- Accelerated cognitive decline in obese mouse model of Alzheimer's disease is linked to sialic acid-driven immune deregulation 96%
- TMEM65-dependent Ca2+ extrusion safeguards mitochondrial homeostasis 95%
Similar papers in this journal
- Single Cell Multimodal Analyses Reveal Epigenomic and Transcriptomic Basis for Birth Defects in Maternal Diabetes 97%
- An engineered human cardiac tissue model reveals contributions of systemic lupus erythematosus autoantibodies to myocardial injury 97%
- SARS-CoV-2 infection triggers pro-atherogenic inflammatory 1 responses in human coronary vessels 96%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.